Femasys Stock Probability Of Bankruptcy

FEMY Stock  USD 1.10  0.05  4.76%   
Femasys' odds of distress is above 80% at this time. It has very high probability of going through financial hardship in the upcoming years. Probability of bankruptcy shows the probability of financial torment over the next two years of operations under current economic and market conditions. All items used in analyzing the odds of distress are taken from the Femasys balance sheet, as well as cash flow and income statements available from the company's most recent filings. Check out Femasys Piotroski F Score and Femasys Altman Z Score analysis.
For more information on how to buy Femasys Stock please use our How to Invest in Femasys guide.
  

Femasys Company probability of bankruptcy Analysis

Femasys' Probability Of Bankruptcy is a relative measure of the likelihood of financial distress. For stocks, the Probability Of Bankruptcy is the normalized value of Z-Score. For funds and ETFs, it is derived from a multi-factor model developed by Macroaxis. The score is used to predict the probability of a firm or a fund experiencing financial distress within the next 24 months. Unlike Z-Score, Probability Of Bankruptcy is the value between 0 and 100, indicating the firm's actual probability it will be financially distressed in the next 2 fiscal years.

Probability Of Bankruptcy

 = 

Normalized

Z-Score

More About Probability Of Bankruptcy | All Equity Analysis

Current Femasys Probability Of Bankruptcy

    
  Over 81%  
Most of Femasys' fundamental indicators, such as Probability Of Bankruptcy, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Femasys is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Our calculation of Femasys probability of bankruptcy is based on Altman Z-Score and Piotroski F-Score, but not limited to these measures. To be applied to a broader range of industries and markets, we use several other techniques to enhance the accuracy of predicting Femasys odds of financial distress. These include financial statement analysis, different types of price predictions, earning estimates, analysis consensus, and basic intrinsic valuation. Please use the options below to get a better understanding of different measures that drive the calculation of Femasys financial health.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Femasys. If investors know Femasys will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Femasys listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.81)
Revenue Per Share
0.047
Quarterly Revenue Growth
(0.31)
Return On Assets
(0.60)
Return On Equity
(1.38)
The market value of Femasys is measured differently than its book value, which is the value of Femasys that is recorded on the company's balance sheet. Investors also form their own opinion of Femasys' value that differs from its market value or its book value, called intrinsic value, which is Femasys' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Femasys' market value can be influenced by many factors that don't directly affect Femasys' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Femasys' value and its price as these two are different measures arrived at by different means. Investors typically determine if Femasys is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Femasys' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
The Probability of Bankruptcy SHOULD NOT be confused with the actual chance of a company to file for chapter 7, 11, 12, or 13 bankruptcy protection. Macroaxis simply defines Financial Distress as an operational condition where a company is having difficulty meeting its current financial obligations towards its creditors or delivering on the expectations of its investors. Macroaxis derives these conditions daily from both public financial statements as well as analysis of stock prices reacting to market conditions or economic downturns, including short-term and long-term historical volatility. Other factors taken into account include analysis of liquidity, revenue patterns, R&D expenses, and commitments, as well as public headlines and social sentiment.
Competition

Based on the latest financial disclosure, Femasys has a Probability Of Bankruptcy of 81%. This is 87.11% higher than that of the Health Care Equipment & Supplies sector and 123.45% higher than that of the Health Care industry. The probability of bankruptcy for all United States stocks is 103.36% lower than that of the firm.

Femasys Probability Of Bankruptcy Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Femasys' direct or indirect competition against its Probability Of Bankruptcy to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Femasys could also be used in its relative valuation, which is a method of valuing Femasys by comparing valuation metrics of similar companies.
Femasys is currently under evaluation in probability of bankruptcy category among its peers.

Femasys Fundamentals

About Femasys Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Femasys's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Femasys using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Femasys based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Femasys Stock Analysis

When running Femasys' price analysis, check to measure Femasys' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Femasys is operating at the current time. Most of Femasys' value examination focuses on studying past and present price action to predict the probability of Femasys' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Femasys' price. Additionally, you may evaluate how the addition of Femasys to your portfolios can decrease your overall portfolio volatility.